Life-Style Health
More than 66 percent of patients treated with the DigniCap reported losing less than half their hair.
Hi, what are you looking for?
More than 66 percent of patients treated with the DigniCap reported losing less than half their hair.
Today I present to you my predictions for Israel’s medical achievements that will take place in the forthcoming new Jewish Year of 5776. They...
Weizmann Institute researchers found a treatment stopped lung cancer cells from developing resistance to chemotherapy in mice
Opko Health (NYSE: OPK; TASE: OPK), controlled by chairman Dr. Phillip Frost, has acquired EirGen Pharma, Ltd., a pharmaceutical company based in Ireland, focused on...
The ubiquitin system produces a protein that greatly restricts the development of cancerous tumors.
The team identified one potential drug molecule that performed quite well, even causing many of the cancer cells to die.
– My instinctive reaction to Monday’s tragic news was to not write a positive news blog this week. But why let the terrorists win? Dry Bones’ cartoon included...
– – Technion researchers developed a novel approach for potential treatment of cancer cells that are resistant to chemotherapy Technion researchers discovered that multidrug...
– Researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center have found a chemical “signature” in blood-forming stem cells that predicts whether patients...
– This approval provides the regulatory framework for the commercialization of Lonquex in all 28 EU countries. – Illustration Teva Pharmaceutical Industries Ltd...